142 related articles for article (PubMed ID: 7911453)
61. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4.
van Roon JA; van Roy JL; Gmelig-Meyling FH; Lafeber FP; Bijlsma JW
Arthritis Rheum; 1996 May; 39(5):829-35. PubMed ID: 8639180
[TBL] [Abstract][Full Text] [Related]
62. CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity.
Carvalheiro H; Duarte C; Silva-Cardoso S; da Silva JA; Souto-Carneiro MM
Arthritis Rheumatol; 2015 Feb; 67(2):363-71. PubMed ID: 25370956
[TBL] [Abstract][Full Text] [Related]
63. Mononuclear cell (MNC) subtypes in osteoarthritis synovial fluid. Comparison with MNC subtypes in rheumatoid arthritis synovial fluid.
Fort JG; Flanigan M; Smith JB
J Rheumatol; 1995 Jul; 22(7):1335-7. PubMed ID: 7562768
[TBL] [Abstract][Full Text] [Related]
64. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
[TBL] [Abstract][Full Text] [Related]
65. Interferon production from peripheral blood, synovial fluid, and synovial tissue lymphocytes in patients with rheumatoid arthritis and ankylosing spondylitis.
Chou CT; Lee W; Chang ML; Lee CF; Kuo SY; Lin YM
J Formos Med Assoc; 1990 Oct; 89(10):845-9. PubMed ID: 1706407
[TBL] [Abstract][Full Text] [Related]
66. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts.
Yu S; Nakashima N; Xu BH; Matsuda T; Izumihara A; Sunahara N; Nakamura T; Tsukano M; Matsuyama T
Rheumatol Int; 1998; 17(6):237-43. PubMed ID: 9592864
[TBL] [Abstract][Full Text] [Related]
67. Effect of cytokine-induced soluble ICAM-1 from human synovial cells on synovial cell-lymphocyte adhesion.
Shingu M; Hashimoto M; Ezaki I; Nobunaga M
Clin Exp Immunol; 1994 Oct; 98(1):46-51. PubMed ID: 7923883
[TBL] [Abstract][Full Text] [Related]
68. Proportion of the CD19-Positive and CD19-Negative Lymphocytes and Monocytes within the Peripheral Blood Mononuclear Cell Set is Characteristic for Rheumatoid Arthritis.
Kholodnyuk I; Kadisa A; Svirskis S; Gravelsina S; Studers P; Spaka I; Sultanova A; Lejniece S; Lejnieks A; Murovska M
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31554310
[No Abstract] [Full Text] [Related]
69. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.
Li J; Shen W; Kong K; Liu Z
Scand J Immunol; 2006 Nov; 64(5):515-22. PubMed ID: 17032244
[TBL] [Abstract][Full Text] [Related]
70. Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA).
Ribbens C; Bonnet V; Kaiser MJ; Andre B; Kaye O; Franchimont N; de Groote D; Beguin Y; Malaise MG
Clin Exp Immunol; 2000 Apr; 120(1):194-9. PubMed ID: 10759783
[TBL] [Abstract][Full Text] [Related]
71. Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.
Combe B; Pope RM; Fischbach M; Darnell B; Baron S; Talal N
Clin Exp Immunol; 1985 Mar; 59(3):520-8. PubMed ID: 3921298
[TBL] [Abstract][Full Text] [Related]
72. Interacting monocytes and synoviocytes induce adhesion molecules by a cytokine-regulated process.
Blue ML; Conrad P; Webb DL; Sarr T; Macaro M
Lymphokine Cytokine Res; 1993 Aug; 12(4):213-8. PubMed ID: 7692987
[TBL] [Abstract][Full Text] [Related]
73. Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis.
Dimitrijevic M; Bartlett RR
Inflamm Res; 1996 Nov; 45(11):550-6. PubMed ID: 8951506
[TBL] [Abstract][Full Text] [Related]
74. [Influence of cytokines on ICAM-1 expression and soluble ICAM-1 production by human endothelial cells].
Hashimoto M
Fukuoka Igaku Zasshi; 1994 Jun; 85(6):178-86. PubMed ID: 7915999
[TBL] [Abstract][Full Text] [Related]
75. Soluble E-selectin in arthritis.
Koch AE; Turkiewicz W; Harlow LA; Pope RM
Clin Immunol Immunopathol; 1993 Oct; 69(1):29-35. PubMed ID: 7691452
[TBL] [Abstract][Full Text] [Related]
76. Elevated Levels of Soluble ST2 were Associated with Rheumatoid Arthritis Disease Activity and Ameliorated Inflammation in Synovial Fibroblasts.
Shi LJ; Liu C; Li JH; Zhu XY; Li YN; Li JT
Chin Med J (Engl); 2018 Feb; 131(3):316-322. PubMed ID: 29363647
[TBL] [Abstract][Full Text] [Related]
77. Accessory molecules expressed on the peripheral blood or synovial fluid T lymphocytes from patients with Sjögren's syndrome or rheumatoid arthritis.
Ichikawa Y; Shimizu H; Yoshida M; Takaya M; Arimori S
Clin Exp Rheumatol; 1992; 10(5):447-54. PubMed ID: 1360883
[TBL] [Abstract][Full Text] [Related]
78. Rheumatoid factor production in the joint.
Breedveld FC; Otten HG; Daha MR
Scand J Rheumatol Suppl; 1995; 101():183-5. PubMed ID: 7747124
[TBL] [Abstract][Full Text] [Related]
79. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
[TBL] [Abstract][Full Text] [Related]
80. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta.
Yin Z; Siegert S; Neure L; Grolms M; Liu L; Eggens U; Radbruch A; Braun J; Sieper J
Rheumatology (Oxford); 1999 Nov; 38(11):1058-67. PubMed ID: 10556256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
